Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2004 1
2006 2
2007 1
2008 1
2009 1
2010 1
2011 1
2012 3
2014 4
2015 3
2016 2
2018 1
2019 2
2020 5
2021 7
2022 5
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote I, Pérez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martínez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Høgdall E, Fariñas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Vergote I, et al. Among authors: klat j. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. J Clin Oncol. 2023. PMID: 37669480 Clinical Trial.
ERAS protocol in gynecologic oncology.
Bajsová S, Klát J. Bajsová S, et al. Among authors: klat j. Ceska Gynekol. 2019 Summer;84(5):376-385. Ceska Gynekol. 2019. PMID: 31826636 Review. English.
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I, Gracia Segovia M, Macuks R, Mancari R, Achimas-Cadariu P, Corrado G, Bartusevicius A, Sukhin V, Muruzabal JC, Coronado Martín PJ, Gardella B, Piek JM, Concin N, Arab C, Papatheodorou D, Polterauer S, Iacoponi S, Nieto T, Lopez-Sanclemente MC, Trukhan H, Gil MM, Bakinovskaya I, Dalamanava A, Cucurull M, Rovski D, Baquedano L, Chiva L, Mardas M, Mavrichev SA, Klat J, Lopez de la Manzanara CA, Yildirim Y; SARCUT Study Group. Zapardiel I, et al. Among authors: klat j. Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204. Int J Gynecol Cancer. 2023. PMID: 37192761
Gynecological tumor triplicity.
Mladěnka A, Šimetka O, Mladěnka P, Klát J. Mladěnka A, et al. Among authors: klat j. Ceska Gynekol. 2018 Winter;83(6):445-447. Ceska Gynekol. 2018. PMID: 30848150 English.
Adverse events of PARP inhibitors.
Romanová Martina, Klát Jaroslav. Romanová Martina, et al. Among authors: klat jaroslav. Ceska Gynekol. 2021;86(1):54-60. doi: 10.48095/cccg202154. Ceska Gynekol. 2021. PMID: 33752410 English.
Th e role of CDK12 in tumor bio logy.
Dzimková M, Procházková J, Klát J, Kohoutek J. Dzimková M, et al. Among authors: klat j. Klin Onkol. 2020 Summer;33(4):260-267. doi: 10.14735/amko2020260. Klin Onkol. 2020. PMID: 32894954 Review. English.
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli MM, Ortiz DI, Falconer H, Abu-Rustum NR, Odetto D, Klát J, Dos Reis R, Zapardiel I, Di Martino G, Presl J, Laky R, López A, Weinberger V, Obermair A, Pareja R, Poncová R, Mom C, Bizzarri N, Borčinová M, Aslan K, Salcedo Hernandez RA, Fons G, Benešová K, Dostálek L, Ayhan A. Cibula D, et al. Among authors: klat j. Gynecol Oncol. 2023 Mar;170:195-202. doi: 10.1016/j.ygyno.2023.01.014. Epub 2023 Jan 25. Gynecol Oncol. 2023. PMID: 36706646 Free PMC article.
Post-recurrence survival in patients with cervical cancer.
Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Scambia G, Ayhan A, Kim SH, Isla Ortiz D, Klat J, Obermair A, Di Martino G, Pareja R, Manchanda R, Kosťun J, Dos Reis R, Meydanli MM, Odetto D, Laky R, Zapardiel I, Weinberger V, Benešová K, Borčinová M, Cardenas F, Wallin E, Pedone Anchora L, Akilli H, Abu-Rustum NR, Barquet-Muñoz SA, Javůrková V, Fischerová D, van Lonkhuijzen LRCW. Cibula D, et al. Among authors: klat j. Gynecol Oncol. 2022 Feb;164(2):362-369. doi: 10.1016/j.ygyno.2021.12.018. Epub 2021 Dec 23. Gynecol Oncol. 2022. PMID: 34955236 Free PMC article.
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy.
Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Falconer H, Querleu D, Ayhan A, Kim SH, Ortiz DI, Klat J, Landoni F, Rodriguez J, Manchanda R, Kosťun J, Ramirez PT, Meydanli MM, Odetto D, Laky R, Zapardiel I, Weinberger V, Dos Reis R, Pedone Anchora L, Amaro K, Salehi S, Akilli H, Abu-Rustum NR, Salcedo-Hernández RA, Javůrková V, Mom CH, Scambia G, Cibula D. Bizzarri N, et al. Among authors: klat j. Obstet Gynecol. 2023 Jan 1;141(1):207-214. doi: 10.1097/AOG.0000000000005026. Epub 2022 Nov 30. Obstet Gynecol. 2023. PMID: 36701621 Free PMC article.
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.
Pignata S, Oza A, Hall G, Pardo B, Madry R, Cibula D, Klat J, Montes A, Glasspool R, Colombo N, Pete I, Herrero Ibáñez A, Marín MR, Ilieva R, Timcheva C, Di Maio M, Blakeley C, Taylor R, Barnicle A, Clamp A. Pignata S, et al. Among authors: klat j. Gynecol Oncol. 2023 May;172:121-129. doi: 10.1016/j.ygyno.2023.03.019. Epub 2023 Apr 6. Gynecol Oncol. 2023. PMID: 37030280 Free article.
45 results